Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 10 (Search time: 0.001 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2023An Insulin-regulated Arrestin Domain Protein Controls Hepatic Glucagon ActionDagdeviren, S.; Hoang, M.F.; Sarikhani, M.; Meier, V.; Benoit, J.C.; Okawa, M.C.; Melnik, V.Y.; Ricci-Blair, E.M.; Foot, N.; Friedline, R.H.; Hu, X.; Tauer, L.A.; Srinivasan, A.; Prigozhin, M.B.; Shenoy, S.K.; Kumar, S.; Kim, J.K.; Lee, R.T.
2021Adaptors as the regulators of HECT ubiquitin ligasesShah, S.S.; Kumar, S.
2020Dietary sodium modulates nephropathy in Nedd4-2-deficient miceManning, J.A.; Shah, S.S.; Henshall, T.L.; Nikolic, A.; Finnie, J.; Kumar, S.
2021Phosphorylation by Aurora B kinase regulates caspase-2 activity and function.Lim, Y.; De Bellis, D.; Sandow, J.J.; Capalbo, L.; D'Avino, P.P.; Murphy, J.M.; Webb, A.I.; Dorstyn, L.; Kumar, S.
2020Ecdysone controlled cell and tissue deletionXu, T.; Jiang, X.; Denton, D.; Kumar, S.
2020Crosstalk between cGAS-STING signaling and cell deathMurthy, A.M.V.; Robinson, N.; Kumar, S.
2021The p53-caspase-2 axis in the cell cycle and DNA damage responseLim, Y.; Dorstyn, L.; Kumar, S.
2023Receptor Recycling by RetromerCarosi, J.M.; Denton, D.; Kumar, S.; Sargeant, T.J.
2023TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasmsShah, M.V.; Tran, E.N.H.; Shah, S.; Chhetri, R.; Baranwal, A.; Ladon, D.; Shultz, C.; Al-Kali, A.; Brown, A.L.; Chen, D.; Scott, H.S.; Greipp, P.; Thomas, D.; Alkhateeb, H.B.; Singhal, D.; Gangat, N.; Kumar, S.; Patnaik, M.M.; Hahn, C.N.; Kok, C.H.; et al.
2022A senescence stress secretome is a hallmark of therapy-related myeloid neoplasm stromal tissue occurring soon after cytotoxic exposureKutyna, M.M.; Kok, C.H.; Lim, Y.; Tran, E.N.H.; Campbell, D.; Paton, S.; Thompson-Peach, C.; Lim, K.; Cakouros, D.; Arthur, A.; Hughes, T.; Kumar, S.; Thomas, D.; Gronthos, S.; Hiwase, D.K.